Global Health Researchers Receive $122 Million to Study Monthly HIV Pill

Global health researchers at the University of Washington have received a $122 million grant from the Bill & Melinda Gates Foundation to test the effectiveness of the candidate drug islatravir, a once-a-month oral pill to prevent HIV.

The five-year grant will support the implementation of a Phase 3, randomized trial of islatravir, among women, in seven countries in sub-Saharan Africa. Islatravir is a nucleoside reverse transcriptase translocation inhibitor in development by Merck for the treatment and prevention of HIV-1 infection.

Global Health Pathway Student Naomi Nkinsi Receives Award to Research Linkages between Food Insecurity and HIV Outcomes

University of Washington Global Health Pathway medical student Naomi Nkinsi has been awarded a new grant to fund research on the effect of food insecurity on antiretroviral therapy and HIV outcomes in South Africa. The $4000 Grant for Emerging Researchers/Clinicians Mentorship (G.E.R.M.) was awarded by the Infectious Diseases Society of America (IDSA) Foundation.

Shaping the future of research and action on STDs and HIV around the globe

Students from around the globe met in Seattle this month to learn cutting-edge research strategies and techniques in the fields of STDs and HIV. 81 students from 14 countries participated in the 26th Annual Principles of STD/HIV Research Course, conducted by UW’s Department of Global Health and Center for AIDS Research. The curriculum focuses on critical research areas in STD/HIV and the fundamentals of different disciplines involved in STD/HIV research.